
Harbin Pharmaceutical Group Co., Ltd.
SSE:600664.SS
Overview | Financials
Company Name | Harbin Pharmaceutical Group Co., Ltd. |
Symbol | 600664.SS |
Currency | CNY |
Price | 3.81 |
Market Cap | 9,595,523,100 |
Dividend Yield | 0% |
52-week-range | 2.54 - 4.97 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Guoren Lin |
Website | https://www.hayao.com |
An error occurred while fetching data.
About Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and trade of pharmaceuticals in China and internationally. The company operates through seven segments: Antibiotics, Small-Molecular Drug Preparations, OTC and Healthcare Products, Modern Chinese Medicines, Biopharmaceuticals, Animal Vaccines, and Medicine Circulations. It offers a series of penicillin and cephalosporin
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD